ReviewJournal of cellular and molecular medicine2019
Helicobacter pylori recrudescence and its influencing factors.
Review in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07040839 (Comparative Efficacy of Omeprazole and Vonoprazan in the Treatment of Helicobacter Pylori Infection), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparative Efficacy of Omeprazole and Vonoprazan in the Treatment of Helicobacter Pylori Infection
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.
- Efficacy and safety ofFrontiers in cellular and infection microbiology · 2025Pooled it
- Current State of Knowledge Regarding WHO High Priority Pathogens-Resistance Mechanisms and Proposed Solutions through Candidates Such as Essential Oils: A Systematic Review.International journal of molecular sciences · 2023Pooled it
- Helicobacter pylori as a Cause of Iron Deficiency in a Menstruating Woman in a Primary Care Setting.Cureus · 2026Article
- Candida serves as a reservoir associating with facilitating the survival and pathogenesis ofFrontiers in microbiology · 2026Article
- Determination of GenesThe Yale journal of biology and medicine · 2025Article
- 2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori.Nature communications · 2025Article
- Fibrosis and cancer intersection.Journal of translational medicine · 2025Article
- Review
- A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population.Current therapeutic research, clinical and experimental · 2025Article
- Comparative evaluation of the accuracy and reliability of ChatGPT versions in providing information onFrontiers in public health · 2025Article
- Review
- Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation.eGastroenterology · 2024Review
- The impact of diet, exercise, and sleep on Helicobacter pylori infection with different occupations: a cross-sectional study.BMC infectious diseases · 2024Article
- A Mini-review onEndocrine, metabolic & immune disorders drug targets · 2024Review
- A review for non-antibiotic treatment ofFrontiers in microbiology · 2024Review
- Article
- Characterization of the unique oral microbiome of children harboringJournal of oral microbiology · 2024Article
- P-CABTherapeutic advances in gastroenterology · 2024Article
- Article
- Probiotic Supplementation for Treatment ofThe Korean journal of helicobacter and upper gastrointestinal research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori (H pylori) is known as one of the most common infectious pathogens, with high infection and recurrence rates worldwide. The prevalence of H pylori is up to 90% in developing countries, while the annual recurrence rate is much higher than that in developed countries. Recurrence can occur either by recrudescence or reinfection. Compared with reinfection, the time window for recrudescence is generally shorter, followed by the recurrence of H pylori-associated diseases in the short-term. Many factors are involved in the H pylori reinfection, such as the prevalence of H pylori infection, living conditions and economic development, health conditions and so forth. Previous studies focused less on H pylori recrudescence. Therefore, the influencing factors for H pylori recrudescence needed further exploration. This study reviewed the recrudescence of H pylori infection and its influencing factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.